» Articles » PMID: 37018843

The Design and Application of DNA-Editing Enzymes As Base Editors

Overview
Publisher Annual Reviews
Specialty Biochemistry
Date 2023 Apr 5
PMID 37018843
Authors
Affiliations
Soon will be listed here.
Abstract

DNA-editing enzymes perform chemical reactions on DNA nucleobases. These reactions can change the genetic identity of the modified base or modulate gene expression. Interest in DNA-editing enzymes has burgeoned in recent years due to the advent of clustered regularly interspaced short palindromic repeat-associated (CRISPR-Cas) systems, which can be used to direct their DNA-editing activity to specific genomic loci of interest. In this review, we showcase DNA-editing enzymes that have been repurposed or redesigned and developed into programmable base editors. These include deaminases, glycosylases, methyltransferases, and demethylases. We highlight the astounding degree to which these enzymes have been redesigned, evolved, and refined and present these collective engineering efforts as a paragon for future efforts to repurpose and engineer other families of enzymes. Collectively, base editors derived from these DNA-editing enzymes facilitate programmable point mutation introduction and gene expression modulation by targeted chemical modification of nucleobases.

Citing Articles

Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer.

Kawale A, Zou L DNA Repair (Amst). 2024; 141:103734.

PMID: 39047499 PMC: 11330346. DOI: 10.1016/j.dnarep.2024.103734.


Exploiting viral vectors to deliver genome editing reagents in plants.

Shen Y, Ye T, Li Z, Kimutai T, Song H, Dong X aBIOTECH. 2024; 5(2):247-261.

PMID: 38974861 PMC: 11224180. DOI: 10.1007/s42994-024-00147-7.


ABE-ultramax for high-efficiency biallelic adenine base editing in zebrafish.

Qin W, Liang F, Lin S, Petree C, Huang K, Zhang Y Nat Commun. 2024; 15(1):5613.

PMID: 38965236 PMC: 11224239. DOI: 10.1038/s41467-024-49943-1.


Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapy.

Burkhardt U, Fritsch E Genes Immun. 2023; 24(6):292-294.

PMID: 38082155 DOI: 10.1038/s41435-023-00227-6.


APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.

McCann J, Cristini A, Law E, Lee S, Tellier M, Carpenter M Nat Genet. 2023; 55(10):1721-1734.

PMID: 37735199 PMC: 10562255. DOI: 10.1038/s41588-023-01504-w.


References
1.
Cheng X . Structure and function of DNA methyltransferases. Annu Rev Biophys Biomol Struct. 1995; 24:293-318. DOI: 10.1146/annurev.bb.24.060195.001453. View

2.
Maeder M, Angstman J, Richardson M, Linder S, Cascio V, Tsai S . Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol. 2013; 31(12):1137-42. PMC: 3858462. DOI: 10.1038/nbt.2726. View

3.
Rallapalli K, Ranzau B, Ganapathy K, Paesani F, Komor A . Combined Theoretical, Bioinformatic, and Biochemical Analyses of RNA Editing by Adenine Base Editors. CRISPR J. 2022; 5(2):294-310. PMC: 9347300. DOI: 10.1089/crispr.2021.0131. View

4.
Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S . Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009; 326(5959):1509-12. DOI: 10.1126/science.1178811. View

5.
Koblan L, Arbab M, Shen M, Hussmann J, Anzalone A, Doman J . Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning. Nat Biotechnol. 2021; 39(11):1414-1425. PMC: 8985520. DOI: 10.1038/s41587-021-00938-z. View